Oncology care:
Keep it going

Learn - Improve - Act

COVID-19 turned out to be a serious treat for cancer patients, in an unpredicted manner. An estimated 2.500 patients in Belgium during April and 5.000 patients in Netherlands during April-May are not yet diagnosed with cancer, due to the Corona outbreak.

Now that we are in the middle of a second wave of COVID-19, HCP, directors and managers can use the best practices to ensure safe and timely cancer diagnosis and treatment during the ongoing pandemic.

Learn more and get access to the full whitepaper by clicking on the button below.

Want to learn more?

Click here to get access to the full whitepaper on “Oncology care: keep it going. Learn – Improve – Act”

ALL-NL-000068 Oct 2020

© Ipsen Group 2019 Ipsen Farmaceutica B.V. Taurusavenue 33B 2132 LS Hoofddorp Tel.: +31 (0)23 – 554 1600